Get started
Osang

APRE: $30 from $15 | a risk free deal

Aprea Therapeutics, Inc. (NASDAQ:APRE)  
Osang Updated   
NASDAQ:APRE   Aprea Therapeutics, Inc.
Beyond Technical Analysis pharmaceuticals biotech Coronavirus (COVID-19) corona novel
1
0
beyondta pharmaceuticals biotech coronavirus corona novel
ahead of the curve going all in
Comment:
it came back to where it started and even way lower
and reversed backed.

cycle
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.